M-A: More than 50 long-term effects of COVID-19.
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis – Scientific Reports Related: Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.” Cohort study: Risk factors for long covid in previously hospitalized children. Viewpoint: The […]
The post M-A: More than 50 long-term effects of COVID-19. appeared first on Links Medicus.
M-A: Asymptomatic SARS-CoV-2 infection – “we estimate that the percentage of infections that never developed clinical symptoms, and thus were truly asymptomatic, was 35.1%”.
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis – Proceedings of the National Academy of Sciences Commentary on Twitter The best comprehensive review of the asymptomatic status with Covid, >350 studies, just out @PNASNews https://t.co/xyfgyGXANLOverall: true, never had symptoms 35%; children 47%@Pratha_Sah @Alison_Galvani @MeaganCFitz @YaleSPH & colleagues(wonder what the rate is w/ Delta) pic.twitter.com/9W6wbvQno6 […]
The post M-A: Asymptomatic SARS-CoV-2 infection – “we estimate that the percentage of infections that never developed clinical symptoms, and thus were truly asymptomatic, was 35.1%”. appeared first on Links Medicus.
PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet Invited Commentary: The use of inhaled corticosteroids in early-stage COVID-19
The post PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community. appeared first on Links Medicus.
Systematic Review: Non-invasive ventilation used at night by people with COPD.
Summary: Non-invasive ventilation (ventilators) used at night by people with chronic obstructive pulmonary disease (COPD) – Cochrane Library Original review: Chronic non‐invasive ventilation for chronic obstructive pulmonary disease – Cochrane Library
The post Systematic Review: Non-invasive ventilation used at night by people with COPD. appeared first on Links Medicus.
Study ties COVID vaccines to lower transmission rates.
Study ties COVID vaccines to lower transmission rates – CIDRAP Original study: Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 – Eurosurveillance
The post Study ties COVID vaccines to lower transmission rates. appeared first on Links Medicus.
A giant trial of COVID-19 treatments organized by the WHO is restarting. Here are the drugs it’s betting on.
A giant trial of COVID-19 treatments is restarting. Here are the drugs it’s betting on – Science Related: WHO Solidarity trial to restart with focus on drugs that act on immune responses caused by Covid-19.
The post A giant trial of COVID-19 treatments organized by the WHO is restarting. Here are the drugs it’s betting on. appeared first on Links Medicus.
‘Breakthrough’ infections do not mean COVID vaccines are failing.
‘Breakthrough’ Infections Do Not Mean COVID Vaccines Are Failing – Scientific American Commentary on Twitter Clear, thorough, reassuring story for people who are worried about breakthrough infections after COVID vaccinations. Even with Delta variant, vaccinated people are extremely well protected & unvaccinated people are extremely vulnerable https://t.co/IT0gCTas56 @ejwillingham @sciam — Laura Helmuth (@laurahelmuth) August […]
The post ‘Breakthrough’ infections do not mean COVID vaccines are failing. appeared first on Links Medicus.
A WHO expert explains why she believes the rush for Covid-19 boosters is premature.
A WHO expert explains why she believes the rush for Covid-19 boosters is premature – STAT Commentary on Twitter Must read interview on rich nations rushing into booster doses Dr @Kate_L_OBrien by @HelenBranswell @statnews "We really have huge inequity right now in just getting primary doses to people. Does a third dose need to […]
The post A WHO expert explains why she believes the rush for Covid-19 boosters is premature. appeared first on Links Medicus.
[Preprint] Phase 1/2 RCT: A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac.
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – medRxiv Commentary on Twitter 6-month follow-up of people aged 60+ in early trials of Sinovac's CoronaVac in China. Authors conclude antibodies dropped too far, but […]
The post [Preprint] Phase 1/2 RCT: A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac. appeared first on Links Medicus.
Covid-19: How effective are vaccines against the delta variant?
Covid-19: How effective are vaccines against the delta variant? – The BMJ
The post Covid-19: How effective are vaccines against the delta variant? appeared first on Links Medicus.